RP11-59G22.1: A GPCR Targeted for Type 2 Diabetes and Chronic Pain
RP11-59G22.1: A GPCR Targeted for Type 2 Diabetes and Chronic Pain
GPR158 (RP11-59G22.1) is a G protein-coupled receptor (GPCR) that is expressed in various tissues, including the brain, pancreas, and gastrointestinal tract. It is involved in the regulation of various physiological processes, including insulin secretion, blood sugar levels, and hormone secretion.
RP11-59G22.1 is a specific transcriptional factor that is highly expressed in the pancreas. It is a key regulator of pancreatic beta-cell function and is involved in the development and maintenance of insulin production. It has also been shown to play a role in the regulation of blood sugar levels and in the development of type 2 diabetes.
RP11-59G22.1 has been identified as a potential drug target for the treatment of type 2 diabetes. Studies have shown that inhibiting RP11-59G22.1 can significantly lower blood sugar levels in individuals with type 2 diabetes, and that this effect is dependent on the levels of RP11-59G22.1.
In addition to its potential use as a drug target, RP11-59G22.1 has also been shown to be a valuable biomarker for the diagnosis and monitoring of type 2 diabetes. The level of RP11-59G22.1 has been shown to be significantly decreased in individuals with type 2 diabetes compared to healthy individuals, and this decrease can be used as a diagnostic marker for this disease.
RP11-59G22.1 has also been shown to play a role in the regulation of other physiological processes, including the regulation of inflammation and the modulation of pain. These functions may be of particular interest for the development of new treatments for chronic pain.
In conclusion, RP11-59G22.1 is a GPCR that is involved in the regulation of various physiological processes, including insulin secretion, blood sugar levels, and hormone secretion. It has been identified as a potential drug target for the treatment of type 2 diabetes and has also been shown to be a valuable biomarker for this disease. Further research is needed to fully understand the role of RP11-59G22.1 in these processes and to develop new treatments for chronic pain.
Protein Name: G Protein-coupled Receptor 158
Functions: Orphan receptor
The "GPR158 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GPR158 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
GPR158-AS1 | GPR15LG | GPR160 | GPR161 | GPR162 | GPR17 | GPR171 | GPR173 | GPR174 | GPR176 | GPR179 | GPR18 | GPR180 | GPR182 | GPR183 | GPR19 | GPR199P | GPR20 | GPR21 | GPR22 | GPR25 | GPR26 | GPR27 | GPR3 | GPR31 | GPR32 | GPR33 | GPR34 | GPR35 | GPR37 | GPR37L1 | GPR39 | GPR4 | GPR42 | GPR45 | GPR50 | GPR52 | GPR55 | GPR6 | GPR61 | GPR62 | GPR63 | GPR65 | GPR68 | GPR75 | GPR75-ASB3 | GPR78 | GPR79 | GPR82 | GPR83 | GPR84 | GPR84-AS1 | GPR85 | GPR87 | GPR88 | GPR89A | GPR89B | GPRACR | GPRASP1 | GPRASP2 | GPRASP3 | GPRC5A | GPRC5B | GPRC5C | GPRC5D | GPRC5D-AS1 | GPRC6A | GPRIN1 | GPRIN2 | GPRIN3 | GPS, PLAT and transmembrane domain-containing protein | GPS1 | GPS2 | GPS2P1 | GPSM1 | GPSM2 | GPSM3 | GPT | GPT2 | GPX1 | GPX1P1 | GPX2 | GPX3 | GPX4 | GPX5 | GPX6 | GPX7 | GPX8 | GRAMD1A | GRAMD1B | GRAMD1C | GRAMD2A | GRAMD2B | GRAMD4 | GRAMD4P2 | GRAMD4P5 | GRAMD4P7 | Granzyme | GRAP | GRAP2
